- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

GSK reports positive data from cholestatic pruritus drug trial

Linerixibat significantly improved cholestatic pruritus in some treatment groups. Credit: GSK.